Health and Social Care Committee

Meeting Venue: Committee Room 1 - Senedd
Meeting date: Thursday, 6 March 2014
Meeting time: 09.10
For further information please contact:
Llinos Madeley Committee Clerk 029 2089 8403 HSCCommittee@wales.gov.uk

Agenda

<AI1>

Private pre-meeting (09.10 - 09.15)

</AI1>

<AI2>

1 Introductions, apologies and substitutions

</AI2>

<AI3>

2 Inquiry into access to medical technologies in Wales: Evidence session 8 (09:15 - 10:05) (Pages 1 - 24)

Cancer Research UK

Emma Greenwood, Head of Policy Development, Cancer Research UK

Clare Bath, Public Affairs Officer for Wales

Dr Tom Crosby, Medical Clinical Director of Velindre Cancer Centre, and the Medical Director of the South Wales Cancer Network

Bernadette McCarthy, Radiotherapy Manager, Velindre Cancer Centre

</AI3>

<AI4>

3 Inquiry into access to medical technologies in Wales: Evidence session 9 (10:05 - 10:50) (Pages 25 - 29)

Genetic Alliance UK

Buddug Cope, Director of Development for Genetic Alliance UK

Emma Hughes, Development Officer for Genetic Alliance UK

Hayley Norris, Patient representative

</AI4>

<AI5>

Break (10.50 - 11.00)

</AI5>

<AI6>

4 Inquiry into access to medical technologies in Wales: Evidence session 10 (11:00 - 12:00) (Pages 30 - 39)

MediWales

Gwyn Tudor, Forum Manager

</AI6>

<AI7>

Lunch (12.00 - 13.00)

</AI7>

<AI8>

5 Inquiry into access to medical technologies in Wales: Evidence session 11 (13.00 - 14.00) (Pages 40 - 53)

Professor Carl Heneghan, Centre for Evidence-Based Medicine, Oxford University

South East Wales Academic Health Science Partnership

Dr Corinne Squire, Manager

West of England Academic Health Science Network

Lars Sundstrom, Director of Enterprise and Translation

Deborah Evans, Managing Director

</AI8>

<AI9>

6 Papers to Note (Pages 54 - 59)

</AI9>

<AI10>

Letter from the Chief Nursing Officer in relation to action points arising from the Committee meeting of 30 January 2014  (Pages 60 - 79)

</AI10>

<AI11>

7 Motion under Standing Order 17.42 to resolve to exclude the public from the meeting for the following business:

Item 8.

</AI11>

<AI12>

8 Consideration of the Minister for Health and Social Services' response to the Committee's letter regarding the follow-up inquiry into stroke risk reduction (14.05 - 14.20) (Pages 80 - 87)

</AI12>

<TRAILER_SECTION>

</TRAILER_SECTION>

<LAYOUT_SECTION>

1.FIELD_TITLE FIELD_FOOTNOTE F_PR

FIELD_SUMMARY

</LAYOUT_SECTION>

<TITLE_ONLY_LAYOUT_SECTION>

2. FIELD_TITLE FIELD_FOOTNOTE F_PR

</TITLE_ONLY_LAYOUT_SECTION>

<HEADING_LAYOUT_SECTION>

FIELD_TITLE

</HEADING_LAYOUT_SECTION>

<TITLED_COMMENT_LAYOUT_SECTION>

FIELD_TITLE

FIELD_SUMMARY

</TITLED_COMMENT_LAYOUT_SECTION>

<COMMENT_LAYOUT_SECTION>

FIELD_SUMMARY

</COMMENT_LAYOUT_SECTION>

<SUBNUMBER_LAYOUT_SECTION>

FIELD_TITLE FIELD_FOOTNOTE F_PR

FIELD_SUMMARY

</SUBNUMBER_LAYOUT_SECTION>

<TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>

FIELD_TITLE FIELD_FOOTNOTE F_PR

</TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>